Dosimetric impacts of Utrecht applicator on three-dimensional brachytherapy for advanced cervical carcinoma
10.3760/cma.j.issn.0254-5098.2019.11.007
- VernacularTitle: 乌德勒支施源器用于局部晚期宫颈癌三维近距离放疗的剂量学研究
- Author:
Tao XUE
1
;
Yunchuan SUN
;
Guangbo LIU
Author Information
1. Department of Radiotherapy and Chemotherapy, Cangzhou Integrated Traditional Chinese and Western Medicine Hospital, Cangzhou 061000, China
- Publication Type:Journal Article
- Keywords:
Cervical cancer;
Brachytherapy;
Utrecht applicator;
Dosimetry
- From:
Chinese Journal of Radiological Medicine and Protection
2019;39(11):837-840
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of Utrecht applicator on dosimetrics of targets and OARs in brachytherapy for advanced cervical cancer.
Methods:Data of patients with locally advanced cervical cancer who received brachytherapy with Utrecht Source Applicator from 2017 to 2018 in the Department of Radiotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hebei province, were collected. The original plan was intracavitary /interstitial brachytherapy (IC/IS-BT). With the original contour and prescription dose unchanged, the implantation was removed and new intracavitary brachytherapy (IC) plan was designed. The dosimetric parameters of IC/IS plan and IC plan were compared and analyzed, and the effect of IS implantation on dose was evaluated.
Results:The D90 of HR-CTV was (88.68±1.84) Gy in IC/IS group and (85.54±0.54) Gy in IC group, with significant difference(t=6.200, P<0.05). In addition, conformity index of the IC/IS plan was significantly higher than that of the IC plan (IC/IS: 0.58±0.08, IC: 0.43±0.05; t=1.010, P<0.05). In terms of OAR, there was no significant difference in dosage between the two groups (P>0.05).
Conclusions:For the brachytherapy of locally advanced cervical cancer, the use of Utrecht Source Applicator can satisfy the prescription dose coverage. Adding IS insertion needle can improve the optimization space of the plan. Without exceeding the dose limit of OAR, the radiation dose to HR-CTV can be significantly increased, and the uniformity of dose distribution can be improved as well.
